Traci E. Battle

1.2k total citations
16 papers, 984 citations indexed

About

Traci E. Battle is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Traci E. Battle has authored 16 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Traci E. Battle's work include Chronic Lymphocytic Leukemia Research (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Traci E. Battle is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Traci E. Battle collaborates with scholars based in United States, Sweden and Germany. Traci E. Battle's co-authors include David A. Frank, Jack L. Arbiser, Francesca Cerimele, Baskaran Govindarajan, Masuko Ushio‐Fukai, Channing J. Der, Xianhe Bai, Keqiang Ye, Wolfgang Dubiel and Gerald A. Soff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Traci E. Battle

15 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Traci E. Battle United States 13 458 344 232 198 192 16 984
Joon‐Seok Choi South Korea 20 569 1.2× 52 0.2× 182 0.8× 60 0.3× 67 0.3× 50 990
Yu‐Chang Liu Taiwan 20 421 0.9× 56 0.2× 177 0.8× 47 0.2× 88 0.5× 34 748
Naoki Wakimoto Japan 15 557 1.2× 48 0.1× 199 0.9× 71 0.4× 98 0.5× 29 947
Zhifei Cao China 23 791 1.7× 19 0.1× 306 1.3× 165 0.8× 162 0.8× 54 1.4k
Yinxue Yang China 23 948 2.1× 20 0.1× 259 1.1× 93 0.5× 115 0.6× 44 1.5k
Hwan‐Mook Kim South Korea 19 502 1.1× 34 0.1× 93 0.4× 81 0.4× 119 0.6× 43 897
Weigang Tong United States 18 632 1.4× 17 0.0× 270 1.2× 80 0.4× 139 0.7× 30 1.4k
Qing‐You Kong China 25 831 1.8× 33 0.1× 308 1.3× 24 0.1× 148 0.8× 47 1.4k
Rohinton S. Tarapore United States 19 669 1.5× 58 0.2× 131 0.6× 18 0.1× 86 0.4× 52 1.1k
Toshinori Bito Japan 22 302 0.7× 28 0.1× 181 0.8× 39 0.2× 198 1.0× 44 1.1k

Countries citing papers authored by Traci E. Battle

Since Specialization
Citations

This map shows the geographic impact of Traci E. Battle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Traci E. Battle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Traci E. Battle more than expected).

Fields of papers citing papers by Traci E. Battle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Traci E. Battle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Traci E. Battle. The network helps show where Traci E. Battle may publish in the future.

Co-authorship network of co-authors of Traci E. Battle

This figure shows the co-authorship network connecting the top 25 collaborators of Traci E. Battle. A scholar is included among the top collaborators of Traci E. Battle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Traci E. Battle. Traci E. Battle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Soff, Gerald A., Wolfgang Dubiel, Masuko Ushio‐Fukai, et al.. (2021). Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo. UNC Libraries.
2.
Kurtzberg, Leslie, Traci E. Battle, Cécile Rouleau, et al.. (2008). Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Molecular Cancer Therapeutics. 7(10). 3212–3222. 30 indexed citations
4.
Battle, Traci E., et al.. (2006). Signal Transducer and Activator of Transcription 1 Activation in Endothelial Cells Is a Negative Regulator of Angiogenesis. Cancer Research. 66(7). 3649–3657. 80 indexed citations
5.
Arbiser, Jack L., Baskaran Govindarajan, Traci E. Battle, et al.. (2006). Carbazole Is a Naturally Occurring Inhibitor of Angiogenesis and Inflammation Isolated from Antipsoriatic Coal Tar. Journal of Investigative Dermatology. 126(6). 1396–1402. 62 indexed citations
6.
Kay, Neil E., Nancy D. Bone, Yean Kee Lee, et al.. (2005). A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells. Leukemia Research. 29(9). 1009–1018. 12 indexed citations
7.
Battle, Traci E., Jack L. Arbiser, & David A. Frank. (2005). The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 106(2). 690–697. 172 indexed citations
8.
Cerimele, Francesca, Traci E. Battle, Rebecca M. Lynch, et al.. (2004). Reactive oxygen signaling and MAPK activation distinguish Epstein–Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proceedings of the National Academy of Sciences. 102(1). 175–179. 120 indexed citations
9.
Friedberg, Jonathan W., Sigui Li, Helen Kim, et al.. (2003). Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. Leukemia Research. 28(2). 139–147. 18 indexed citations
10.
Bai, Xianhe, Francesca Cerimele, Masuko Ushio‐Fukai, et al.. (2003). Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo. Journal of Biological Chemistry. 278(37). 35501–35507. 306 indexed citations
11.
Battle, Traci E., Hugo Castro‐Malaspina, John G. Gribben, & David A. Frank. (2003). Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis. Leukemia Research. 27(9). 859–863. 8 indexed citations
12.
Battle, Traci E. & David A. Frank. (2003). STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1. Blood. 102(8). 3016–3024. 38 indexed citations
13.
Battle, Traci E., William G. Wierda, Laura Z. Rassenti, et al.. (2003). In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.. PubMed. 9(6). 2166–72. 24 indexed citations
14.
Battle, Traci E. & Andrew Yen. (2002). Ectopic Expression of CXCR5/BLR1 Accelerates Retinoic Acid- and Vitamin D3-Induced Monocytic Differentiation of U937 Cells. Experimental Biology and Medicine. 227(9). 753–762. 4 indexed citations
15.
Battle, Traci E., Mark S. Roberson, Tong Zhang, Susi Varvayanis, & Andrew Yen. (2001). Retinoic acid-induced blr1 expression requires RARα, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. European Journal of Cell Biology. 80(1). 59–67. 38 indexed citations
16.
Battle, Traci E., Roy A. Levine, & Andrew Yen. (2000). Retinoic Acid-Induced blr1 Expression Promotes ERK2 Activation and Cell Differentiation in HL-60 Cells. Experimental Cell Research. 254(2). 287–298. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026